Develop a Game Plan to Manage Risks of Biocompatibility

A medical device or material that comes in contact with a patient's body is expected to perform without the occurrence of any harm to the patient.
The U.S. Food and Drug Administration (FDA) and Medical Device Regulation (MDR) are urging greater regulatory requirements for medical devices, which is also reflected in the assessment of biocompatibility. 

Join our webinar to learn more: 

• Overall biological evaluation strategy 
• Challenges in evaluation of biocompatibility 
• Key factors affecting biocompatibility 
• Fundamentals of biological evolution plan 
  • Device description 
  • Material characterization 
  • Chemical characterization 
  • Selection of biocompatibility tests 
  • Reason for not conducting tests 

Speaker: Sairam Arava, UL staff engineer

Upcoming webinars related to biocompatibility:

June, 2021: Constituting Chemical Characterization Study 

September, 2021: Cleaning Validation of Reusable Medical Devices

November, 2021: Toxicological Risk Assessment of Medical Devices and Biological Evaluation Report